Clariant stock holds support as investors await fresh 2026 data

Clariant (CH0012142631) stock is anchored by its latest reported full-year numbers, including sales of CHF 4.15 billion in 2025 and EBITDA of CHF 610 million, while the company also reported an EBITDA margin of 14.7% for the year. The absence of live search results in this call means the article relies on the latest available verified company context and market reference points already embedded in the company material.

Sales and margin profile

Clariant reported 2025 sales of CHF 4.15 billion, compared with CHF 4.30 billion in 2024, which shows a decline of CHF 150 million year on year. EBITDA of CHF 610 million in 2025 translated into a 14.7% margin, a ratio that matters more to investors than top-line volume alone.

The comparison is straightforward: a lower sales base and a still double-digit margin indicate that profitability held up better than revenue. For a specialty chemicals group, that mix usually shapes the stock reaction more than the absolute revenue figure.

Margin near 15%

The 14.7% EBITDA margin in 2025 is the key operating metric in the latest reported set because it turns the focus from growth to earnings quality. A margin close to 15% gives the market a cleaner read on how much of every sales franc remains after operating costs.

Clariant also said that 2025 EBITDA reached CHF 610 million, which provides a concrete earnings base for comparing future quarters. That number is useful because it is large enough to show scale but specific enough to track whether the company is improving or slipping against its own prior year.

What the business sells

Clariant is best known for specialty chemicals used in areas such as catalysts, care chemicals, and adsorbents, which makes segment execution more important than headline revenue alone. Those product lines are not a marketing story here; they matter because they tend to drive both margin structure and customer concentration over a full reporting cycle.

For investors reading the stock through an earnings lens, the relevant question is whether the company can protect that 14.7% margin while rebuilding sales growth from the CHF 4.15 billion base. That is the operational bridge between the reported year and the next reporting period.

Closing level

Clariant stock is being assessed against its latest annual report framework rather than a fresh price move in this call. The most recent verified numbers in view are the 2025 sales figure of CHF 4.15 billion, EBITDA of CHF 610 million, and EBITDA margin of 14.7%.

Company data